Part of a network of leading biomedicine research centers in southern Europe, the CMCiB provides support to more than 150 researchers from different international institutions. In recent months, the CMCiB has also been key in supporting research on COVID-19. It’s custom-built facilities are equipped with the most recent technology, which now includes several state-of-the-art imaging systems from Canon Medical.
Preclinical research of the future
“Our goal is to help shape preclinical research of the future and so we have invested in the best tools available,” said Dr. Manel Puig, Director of the associated ‘parent’ organization, the Institute for Health Science Research Germans Trias i Pujol (IGTP).
Opting for the latest systems
The CMCiB chose several of Canon Medical’s latest systems including the Vantage Galan 3T/Saturn X Gradient MRI, Alphenix Core+ Interventional System, and Olea and ViTAL post-processing software.
“With this equipment in our workplace, we can tackle highly competitive projects and advance medicine in our own hospital and other hospitals in Europe, as well as biotechnology companies and companies in the field of innovation, such as the development of medical devices.” remarked Sara Capdevila, Technical Director at the CMCiB. “The combination of high-end MRI using the Vantage Galan 3T/Saturn X Gradient and Interventional Radiology allows us to support the design and validation of new intravascular medical devices. The Alphenix Core+ is quite unique in the field of preclinical research in Europe, and its features will bring a clear quantitative improvement in the research that we carry out.”
You can read the CMCiB’s experts’ feedback on the new Canon Medical systems in our VISIONS article.
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.